Verition Fund Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-346,490
Closed -$3.48M 3796
2024
Q4
$3.48M Buy
+346,490
New +$3.47M 0.01% 1158

Other funds holding TDACU

Verition Fund Management's TDACU Position: Q1 2025 in Review

Verition Fund Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 346,490 shares — an estimated $3.48M sold.

Verition Fund Management first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $3.48M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • Verition Fund Management reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 346,490 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $3.48M.
  • Verition Fund Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • Verition Fund Management's Translational Development Acquisition Corp Units position peaked at $3.48M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.